FDA Releases Draft Guidance for MDI and DPI Drug Products

Summary

The Food and Drug Administration (FDA) has made available a draft guidance document outlining the required chemistry, manufacturing, and controls documentation for new drug applications and abbreviated new drug applications for metered dose inhalation aerosols, metered dose nasal aerosols, and inhalation powders.